Inducible nitric oxide synthase expression in human colorectal cancer: Correlation with tumor angiogenesis

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 793-801

  Cianchi, Fabio ^a,b   Cortesini, Camillo ^a   Fantappiè, Ornella ^a   Messerini, Luca ^a   Schiavone, Nicola ^a   Vannacci, Alfredo ^a   Nistri, Silvia ^a   Sardi, Iacopo ^a   Baroni, Gianna ^a   Marzocca, Cosimo ^a   Perna, Federico ^a   Mazzanti, Roberto ^a   Bechi, Paolo ^a   Masini, Emanuela ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Azienda Ospedaliero Universitaria Careggi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CYCLIC GMP; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARAFFIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DENSITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR VASCULARIZATION; UPREGULATION; WESTERN BLOTTING;

EID: 0037372178     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63876-X     Document Type: Article

References (51)

1. Moncada S, Palmer RM, Higgs E: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142
2. Nathan C, Xie QW: Nitric oxide synthase: roles, tolls, and controls. Cell 1994, 78:915-918
3. Bredt DS, Snyder SH: Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994, 63:175-195
4. Marietta MA: Nitric oxide synthase structure and mechanism. J Biol Chem 1993, 268:12231-12234
5. Forstermann U, Kleinert H: Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedebergs Arch Pharmakol 1995, 352:351-364
6. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990, 87:1620-1624
7. Hibbs JB, Taintor RR, Vavrin Z, Granger DL, Drapier J-C, Amber IJ, Lancaster JR: Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets in intracellular iron. Nitric Oxide from L-Arginine: A Bioregulatory System. Edited by S Moncada, EA Higgs. Amsterdam, Elsevier, 1990, pp 189-223
8. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S: Nitric oxide activity in human gynecological cancer. Cancer Res 1994, 54:1352-1354
9. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995, 72:41-44
10. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, Ziche M: Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998, 90:587-596
11. Franchi A, Gallo O, Paglierani M, Sardi I, Magnelli L, Masini E, Santucci M: Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis. Head Neck 2002, 24:16-23
12. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC: Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998, 58:334-341
13. Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Sean MO, Harrington AM, Shields PG, Felley-Bosco E, Hussain SP, Harris CC: Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst 1999, 91:86-88
14. Ropponen KM, Kellokoski JK, Lipponen PK, Eskelinen MJ, Alanne L, Alhava EM, Kosma VM: Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis. Scand J Gastroenterol 2000, 11:1204-1211
15. Yagihashi N, Kasajima H, Sugai S, Matsumoto K, Ebina Y, Morita T, Murakami T, Yagihashi S: Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch 2000, 436:109-114
16. Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R, Tanaka M: Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 1999, 70:222-229
17. Hao XP, Pretlow TG, Rao JS, Pretlow TP: Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Cancer Res 2001, 61:419-422
18. Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A: Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996, 17:1171-1174
19. Ahn B, Ohshima H: Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res 2001, 61:8357-8360
20. Felley-Bosco E: Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Met Rev 1998, 17:25-37
21. Fukumura D, Jain RK: Role of nitric oxide in angiogenesis and microcirculation in tumor. Cancer Met Rev 1998, 17:77-89
22. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995, 92:4392-4396
23. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997, 99:2625-2634
24. Ziche M, Morbidelli L, Masini E, Granger HJ, Geppetti P, Ledda F: Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 1993, 15:437-442
25. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ: Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA, 93:15069-15074
26. Cianchi F, Cortesini C, Bechi P, Fantappiè O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E: Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 2001, 121:1339-1347
27. Jass JR, Sobin LH: Histological typing of intestinal tumors. WHO International Histological Classification of Tumors. Berlin, Springer-Verlag, 1989
28. Fleming ID, Cooper JS, Henson DE, Hutter RJP, Kennedy BJ, Murray GP, Sobin LH, Yarbro JW: AJCC Cancer Staging Manual. Philadelphia, Lippincott, 1997
29. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparrini G: Tumour angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992, 84:1875-1887
30. Bani D, Masini E, Bello MG, Bigazzi M, Bani Sacchi TB: Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995, 55:5272-5275
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275
32. Steiner AL, Parker CW, Kipnis DM: Radioimmunoassay for cyclic nucleotides. J Biol Chem 1972, 247:1106-1113
33. Harper JF, Brooker G: Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2′0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res 1975, 1:207-218
34. Gentilini P, Laffi G, Meacci E, La Villa G, Cominelli F, Pinzani M, Buzzelli G: Effects of OKY 046, a thromboxane synthase inhibitor on renal function in non azotemic cirrhotic patients with ascites. Gastroenterology 1988, 94:1470-1477
35. Jenkins DC, Charles SA, Baylis SA, Lelchuk R, Radomski MW, Moncada S: Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 1994, 70:847-849
36. Fantappiè O, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A, Mazzanti R: The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 2002, 35:843-851
37. Pertschuk LP, Feldman JG, Kim DS, Nayeri K, Eisenberg KB, Carter AC, Thelmo WT, Rhong ZT, Benn P, Grossman A: Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer. Cancer 1993, 71:162-171
38. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS: Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995, 55:4575-4580
39. Kondo Y, Arii S, Mori A, Furutani M, Chiba T, Imamura M: Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin Cancer Res 2000, 6:622-630
40. Ignarro LJ: Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991, 41:485-490
41. Xie K, Huang S, Dong Z, Juang S-H, Gutman M, Xie Q-W, Nathan C, Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995, 181:1333-1343
42. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC: Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res 2000, 6:4739-4744
43. Lala PK: Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy. Cancer Met Rev 1998, 17:1-6
44. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93:705-716
45. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS: Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 2002, 62:165-170
46. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 338:58-61
47. Blood CH, Zetter BR: Tumor interaction with the vasculature: angiogenesis and tumor metastases. Biochim Biophys Acta 1990, 1032:89-118
48. Fidler IJ, Ellis LM: The implications of angiogenesis for the biological and therapy of cancer metastasis. Cell 1994, 79:185-188
49. Tanigawa N, Amaya H, Matsumura M, Lu C, Kitaoka A, Matsuyama K, Muraoka R: Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 1997, 57:1043-1046
50. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995, 55:3964-3968
51. Thomsen LL, Scott JMJ, Topley P, Knowles RG, Keerie A-J, Frend AJ: Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo. Studies with 1400W, a novel inhibitor. Cancer Res 1997, 57:3300-3304